"As biotech companies secure funding and advance their drug development programs, the demand for our services is expected to increase." CEO, CMC PHARMACEUTICALS How did 2023 unfold for CMC Pharmaceuticals? One of the key highlights in 2023 was our continued collaboration with the Department of Defense, particularly on Nerve Agent Defense programs. We successfully expanded our portfolio of pharmaceutical countermeasures for the US government, which was a significant accomplishment for us.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with André
Contact André, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack